Posted inFuture Neuralink Gets The FDA Go-Ahead June 1, 2023 We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our…— Neuralink (@neuralink) May 25, 2023 Post navigation Previous Post Swiss Scientists Rebuild Spinal Cord With AINext PostCompany of the week